Precision NanoSystems ULC: federal grants and contributions: 3 agreements; $14.8M value; 2 departments; 3 programs.
Assay record ASY-CA-19PHK6X135 · Cite as: Assay Systems, “Precision NanoSystems ULC: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/precision-nanosystems-ulc/
This project aimed to help advance the development of a COVID-19 vaccine candidate through pre-clinical studies and clinical trials.
This project aimed to establish Canada’s first end-to-end manufacturing of genetic medicines for the production of nanomedicine-based RNA vaccines, gene therapies and cell therapies.
This project will support the firm in their development of a comprehensive lipid nanoparticle reagent technology and product line for the non-viral delivery of nucleic acids for both research and therapeutic applications. Combined with the firm’s suite of microfluidics-based instruments for lipid nanoparticle production, the new reagents developed in this project will enable a complete platform solution for the discovery, development and clinical manufacturing of genetic medicines.
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.